Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer - Rasul, S; Hartenbach, M; Wollenweber, T (European Journal of Nuclear Medicine and Molecular Imaging, 2021)